Easing the Burden of Noncommunicable Diseases: Insights from Early-Stage NCD Program Efforts

Over the past couple of years, the global community has taken great steps to begin addressing the rising burden of NCDs and their impact on millions of people each year. With the support of Medtronic Philanthropy, several local organizations have been building awareness, influencing policy, strengthening health systems and improving access to NCD care across the globe. In this compendium, 19 case studies illustrate the bold programs and campaigns that universities and non-profit organizations have mobilized to help address NCDs as the next chapter in global health.

The report can be found here: Easing the Burden of Noncommunicable Diseases.

A question of design: The role of donations in advancing greater access to health for all

On April 11, 2018, Rabin Martin’s President & CEO Jeff Sturchio gave a keynote address on the role of donations in advancing greater access to health for all at the Partnership for Quality Medical Donations Global Health Policy Forum. The event brought together senior public, NGO and private-sector professionals to discuss strategies and solutions for multisectoral engagement and partnership development.
read more

Spotlight on oncology: Increasing access to patient-centered cancer care

As the global burden of disease shifts from infectious to chronic, non-communicable diseases, health systems and industry are tackling these challenges by focusing on how to provide personalized, patient-centered care to all people who need it, while considering issues around cost and value of innovation. Having just returned from the World Cancer Congress in ...

read more

Diabetes: Rethinking Novo Nordisk’s global strategy for access to care

Novo Nordisk came to us with a question: How could the company help improve access to diabetes care for patients around the world? We initiated a comprehensive re-assessment of the company’s access strategy, benchmarked novel approaches and gained feedback from more than 40 stakeholders, helping Novo Nordisk identify the opportunity to build on its legacy as the leading diabetes company in the world by working to close the global gap in access to insulin.
read more

New strategies for clinical research for the developing world

The objective of medical research is to develop interventions to improve the health of individuals, communities and populations. But many women, especially those who are pregnant, have been left out when it comes to testing the effectiveness of new medicines.  We helped convene a conference in Geneva, Switzerland to raise awareness and explore potential solutions on this issue.
read more